Antibody to Adalimumab ELISA
Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Adalimumab (Humira®) in serum and plasma.
The solid phase (MTP) is coated by the drug Adalimumab. Due to the assay design this test only measures the free antibodies which are not bound to Adalimumab. Results are expressed in AU (arbitrary units).
Reference: IG-BB103
Barcode: 8682754930110
Legal Status: CE-Mark
Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Quality Control Certificates
Quality Control Certificate Lot: BB103-208 310.52 KB
Quality Control Certificate Lot: BB103-207 308.74 KB
Quality Control Certificate Lot: BB103-206 308.65 KB
Quality Control Certificate Lot: BB103-205 306.69 KB
Quality Control Certificate Lot: BB103-204 323.99 KB
Quality Control Certificate Lot: BB103-203 76.67 KB
Quality Control Certificate Lot: BB103-202 76.71 KB
Humira® is trademark of Abbott Laboratories.
The Kit at a glance:
| Required Volume (µL) | 50 |
| Incubation Time (min) | 135 |
| Sample | Serum, Plasma |
| Package Size | 96 |
| Results in | Qualitative&Quantitative(ng/mL) |
| Shelf Life (years) | 2 |